
Saim Korlu
Verified Expert in Management Consulting
Management Consulting Expert
London, United Kingdom
Toptal member since September 18, 2018
Saim is a financial and strategic advisor with a strong track record. Over his 25-year career, Saim completed 35+ transactions worth over $35 billion while working at the world's pre-eminent institutions, including J.P. Morgan & Co. (New York), The Carlyle Group (New York), and PineBridge Investments (Bahrain). Saim is an expert practitioner in M&A, private equity, fundraising, financial analysis/forecasting, project and acquisition finance, and post-merger integration.
Career Highlights
Education Highlights
Case Studies
Expertise
- Complex Transaction Agreements
- Cross-border M&A
- Due Diligence
- Investment Banking
- Mergers & Acquisitions (M&A)
- Middle East
- Private Equity
- Share Purchase Agreements
Work Experience
Managing Partner
Prospera Capital Partners
- Acted as the chief investment officer at Kennis Wiser Capital, a private equity fund focused on UK social housing. Led the fund's launch; spearheaded the assessment and underwriting of prospective investments. Executed fundraising strategies.
- Advised Ignite Power, a solar energy access company, on its $40mn acquisition of Engie SA’s solar and mini-grid businesses in Sub-Saharan Africa. Led the end-to-end execution of this strategic transaction.
- Advised Ardian, a European infrastructure private equity firm, on its €50 million acquisition of a wind energy asset in Germany.
- Advised Sestek Voice Technologies, an AI-based conversational software company, on its cross-border sale to Unifonic Inc., a UAE-based Softbank portfolio company.
- Acted as an expert witness at an ICC-London arbitration case on behalf of NBK Capital Partners, a private equity firm, with respect to matters involving private equity fund structures and terms.
- Advised ciceksepeti.com, a flowers and gifts-focused eCommerce company, on M&A, corporate development, joint ventures, and fundraising initiatives.
- Advised DAIO Corp., a $4.0 billion Japanese paper and packaging group, on its cross-border acquisition of SCA Hygiene Products from Pladis for $35 million. Led the calculation, mediation, and settlement of the post-closing purchase price adjustment.
- Advised the European Bank of Reconstruction and Development (EBRD) concerning debt financing for a recycled-materials manufacturer.
- Sourced and led $30 million of equity investment in Alcazar Energy, a solar and wind energy firm. Advised Alcazar Energy on the acquisition of 50MW greenfield wind energy licenses.
Group Head, Private Equity – MENA & Turkey
PineBridge Investments
- Built a market map that highlighted the positioning of 10 companies in the specialty chemicals sector.
- Identified a leading company in the market, developed a relationship with the owners, executive managed the team, and led a $130 million investment.
- Built the bottoms-up financial forecast and the LBO model.
- Managed the financial, commercial, operational and legal due diligence.
- Spearheaded deal negotiations, arranged the acquisition debt financing, and negotiating the term sheet and the credit agreement with the banks.
- Developed presentation materials for the investment committee and the board of directors.
- Identified, presented to, and negotiated with co-investors.
- Originated and executed a $30 million investment in a $135 million renewable energy platform investment.
- Identified the opportunity through a direct relationship with the CEO and led the term sheet negotiations, due diligence, and the preparation and presentation of detailed materials to the investment committee.
- Served as a board director and vice chairman of the credit approval committee of a factoring company with $275 million of assets.
- Realized a partial exit by extracting 20% of the initial investment as dividends.
- Helped grow the company's market share by 2.5x, assets by 5x, and book value by 6x over two years by arranging new debt financing to underwrite new loans, evaluating and approving add-on acquisitions and monitoring performance, reviewing budgets, analyzing and approving new loan requests.
- Led and coached PineBridge's private equity team.
Director
Actera Group
- Originated and completed—on a proprietary and exclusive basis—a $150 million investment in a logistics and aviation company with an enterprise value of $600 million.
- Raised $90 million of acquisition debt financing.
- Sourced and led the execution of investments in the education, healthcare, infrastructure, and agriculture industries.
- Managed and coached a team of eight junior mid-level and junior staffers.
- Acted as a director on the boards of four portfolio companies operating in the financial services, media and entertainment, retail, and food services sectors.
Vice President
J.P. Morgan & Co.
- Led the sell-side M&A and staple financing transaction for North Castle Partners' $720 million exit of its portfolio company, CRC Health, in a dual track initial public offering and sale process.
- Completed the sale of the company to Bain Capital, resulting in 6x return on capital.
- Drafted the information memorandum and IPO prospectus; preparing the financial projections, DCF, and LBO-based valuation materials.
- Coordinated the due diligence, negotiated the SPA, and spearheaded the closing process.
- Led various sell-side transactions including Alpha Therapeutics' break-up and two-part sale to Baxter and Probitas for $100 million, LabOne’s sale to Quest Diagnostics for $1 billion, Oratec’s sale to Smith & Nephew for $300 million, and Edwards Lifesciences’ sale of its services business to Fresenius for $50 million.
- Led the buy-side M&A advisory for Guidant Corporation's $2.5 billion acquisition of Cook Group.
- Built and presented the bottoms-up financial forecast and comparables-based valuation model.
- Prepared pro forma financial impact analysis including EPS accretion/dilution and EPS growth.
- Designed and presented transaction structure alternatives and drafted the public announcement materials.
- Led the buy-side advisory on various M&A transactions including Madison Dearborn Partners’ buy-out of VWR for $4 billion, McKesson’s acquisition of Fisher Scientific for $12 billion, Bristol-Myers Squibb's acquisition of DuPont Pharmaceuticals for $7.8 billion, and EcoLab’s $73 million minority investment in KIK.
- Led the $779 million public equity raise for King Pharmaceuticals.
- Drafted the offering prospectus and prepared the valuation materials to establish the offering price.
- Presented the investment merits and risks to the equities sales force and responded to inquiries from the SEC and investors.
- Built the equity book and oversaw its completion.
- Led various equity raise transactions including Universal American Financial's $180 million offering, Endo Pharmaceuticals' $91 million offering, and Thoratec Corporation's $112 million offering.
- Led the $2 billion acquisition debt financing for Fillmore Capital Partner’s buy-out of Genesis Healthcare and was responsible for various areas including performing the debt capacity analysis.
- Constructed the credit model and covenant stress test.
- Drafted and presented ratings advisory presentation; also prepared the credit approval presentation.
- Wrote and negotiated the financing terms sheet and the credit agreement.
- Led various debt raise transactions including the $2.6 billion financing for MDP's buyout of VWR, the $350 million financing for Bain Capital’s buyout of CRC Health, the $50 million financing for CRC Health’s acquisition of Aspen Education, the $225 million financing for Patheon, and the $345 million convertible offering for King Pharmaceuticals.
- Spearheaded and completed various strategic advisory mandates including advising the board of directors of Universal Health Services to defend against a hostile bidder, advising the board of directors of Extendicare on its strategic alternatives, building an international expansion strategy for Henry Schein.
- Structured and financed McKesson Corporation's $2 billion class-action lawsuit.
Private Equity Associate
The Carlyle Group
- Led the LBO of Talecris Pharmaceuticals and raised $100 million of asset-based acquisition debt financing from J.P. Morgan and was responsible for building a dynamic LBO model with return sensitivities.
- Spearheaded the due diligence and determined the transaction structure.
- Solicited acquisition debt offers from banks and negotiated the SPA and credit agreement.
- Identified and interviewed CEO candidates and prepared the post-closing 100-day and value creation plans.
- Monetized Carlyle’s investment in Empi, generating shareholder profits of $140 million, ROI of 3.2x, and IRR of 30%.
- Executed the $75 million dividend recapitalization of Empi, resulting in a full return of the initial investment followed by a $175 million dual-track sale and IPO process, resulting in complete exit from the investment.
- Maintained responsibility for the solicitation and review of advisory, staple financing, and IPO underwriting proposals from banks.
- Prepared the buyer list, managed the due diligence and reviewed the management presentation, IPO prospectus, and equity sales force memorandum.
- Reviewed and negotiated the offer letters from bidders, negotiated the SPA with final bidders, and prepared the closing checklist and the funds flow.
- Completed InteliStaf’s, a portfolio company, $50 million acquisition of competitor Star-Med and was responsible for designing the share-swap deal structure.
- Identified and modeled the synergies and resulting value creation for InteliStaf.
- Prepared and presented the memorandum to the investment committee.
- Drafted and negotiated the SPA and SHA.
- Laid out post-close integration and organizational structure and oversaw the closing process.
- Completed MedPointe Pharmaceutical’s in-licensing transaction for a $200 million revenue product from AstraZeneca.
Education
Bachelor's Degree in Industrial Engineering and Economics
Northwestern University - Evanston, IL, USA
Skills
Finance
Cash Flow Modeling, Valuation Modeling, M&A Modeling, Revenue Modeling, Project Evaluation, Revenue & Expense Projections, Financial Advisory, Investment Memoranda, Investment Monitoring, Investment Summaries, Minority Investments, Finance Strategy, Budgeting, Capital Budgeting, P&L Forecasting, Cash Flow Forecasting, Forecasting, Debt Structuring, Finance Structures, Capital Structuring, Capital Structure Optimization, Capital Structure Analysis, Private Equity Valuation, Private Company Valuation, Comparable Company Analysis, Bank Covenants, M&A Earn-out Agreements, Credit Analysis, Equity Offerings, Equity Valuation, Growth Equity, Valuation Multiples, Financial Planning & Analysis (FP&A), Three-statement Modeling, Credit Risk, Credit Reviews, Funds Flow, Term Loans, Recapitalization, Management Buyout Finance, Investment Return Scenario Analysis, Pro Forma Financial Statements, Equity Capital, Equity Raises, Debt, Bank Debt Raises, Share Buybacks, DCF Valuation, Discounted Cash Flow (DCF), Transaction Structuring, Financial Modeling, Corporate Finance, Investment Briefs, Investment Thesis, Subordinated Debt, Project Finance, Value Investing, Projected Cash Flow, Financial Options, Equity Financing, Transaction Modeling, Debt Raises, Due Diligence, Value Creation, Mergers & Acquisitions (M&A), Investment Portfolio Management, M&A (Buy-side), M&A (Sell-side), Private Equity, Leveraged Buyout Modeling, Cross-border M&A, Funding Strategy, Capital Raising, Fundraising, Dividend Policy, Accounting, Financial Management, Debt Restructuring, Financial Engineering, Expense Reduction, Cost-saving Structure, Commercial Mortgage-backed Securities (CMBS), Intangible Asset Valuation, Asset-based Finance, Funding Process, Fund Governance, Asset Valuation, Asset-based Lending, Convertible Debt, Debt Workouts, Financial Systems, Risk Models, Sales Expense Forecasting, Valuation
Output Software
Microsoft Word, Microsoft Excel, Microsoft PowerPoint
Data & Analysis Software
Financial Data, Capital IQ, Bloomberg
Industry Expertise
Debt Capital Markets, Aviation, Healthcare, Banking & Finance, Venture Capital
Geographic Expertise
United States, Turkey, Bahrain, EMEA, United Arab Emirates, Middle East
Other
Acquisitions, Business Planning, Feasibility Studies, Investor Presentations, Post-merger Integration, Portfolio Management, Portfolio Company Support, Models, Financial Closing, Financials, Contract Negotiation, Negotiation, RFP Negotiation, Price Negotiations, Terms & Conditions, Legal Structuring, Legal Documentation, Legal Contract Drafting, Leveraged Finance, Finance, Exit Strategy, Strategy, Investment Cases, Investing, Investment Funds, Scenario Analysis, Pro Forma Analysis, Emerging Growth Companies, Initial Public Offerings, Equity, Equities, Investments, Credit Modeling, Credit Ratings, Loans, Buyer Lists, Exit Planning, Sell-side, Pitch Decks, Complex Transaction Agreements, Accretion/Dilution Analysis, Investment Ideas, Investment Research, Investment Committee Advisory, Investment Capital Raising, Board Development, BOD, Debt Financing, Debt Issuance, Project Papers for Proposed Financing, SME/SMB Financing, Financing, Strategic Planning & Execution, Business Strategy, Growth Strategy, Entry Strategy, Quality of Earnings, Transaction Advisory, Transaction Comparables, Precedent Transaction Analysis, Share Purchase Agreements, Term Sheets, Term Sheet Advisory, Term Sheet Negotiations, DCF Modeling, Board Presentations, Shareholder Value, Modeling, Leveraged Buyout (LBO), Board Work, Boards, Equity Investment, Education, Emerging Markets, Investment Banking, Financial Analysis, Investor Relations, Investor Agreements, Integration, Merger Benefits, Acquisition Analysis, Company Strategy, Management Consulting, Growth Strategy Consultants, Pitch Deck Consultant, Strategic Initiatives, Strategic Partnerships, Strategic Planning, Investment Analysis, Limited Partnerships, Business Development, Fundraising Consultant, Business Services, Asset Securitization, Assets, ProModel EPS, Market Entry, Chief Strategy Officer (CSO), Buyouts
How to Work with Toptal
Toptal matches you directly with global industry experts from our network in hours—not weeks or months.
Share your needs
Choose your talent
Start your risk-free talent trial
Top talent is in high demand.
Start hiring